Encompass Health Corporation Proceeds from Sale and Maturity of Debt Securities, Available-for-sale
Encompass Health Corporation (EHC) reported Proceeds from Sale and Maturity of Debt Securities, Available-for-sale of $10.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities · last filed 2026-08-07
- Encompass Health Corporation proceeds from sale and maturity of debt securities, available-for-sale for the quarter ending 2026-06-30 was $10.80M, a 24.14% increase year-over-year.
- Encompass Health Corporation proceeds from sale and maturity of debt securities, available-for-sale for the quarter ending 2026-03-31 was $10.30M.
- Encompass Health Corporation proceeds from sale and maturity of debt securities, available-for-sale for the quarter ending 2025-12-31 was $7.30M.
- Encompass Health Corporation proceeds from sale and maturity of debt securities, available-for-sale for the quarter ending 2025-09-30 was $16.30M.
- Encompass Health Corporation proceeds from sale and maturity of debt securities, available-for-sale for fiscal 2025 was $32.30M.
- Encompass Health Corporation proceeds from sale and maturity of debt securities, available-for-sale for fiscal 2024 was $0.00.
- Encompass Health Corporation proceeds from sale and maturity of debt securities, available-for-sale for fiscal 2023 was $0.00.
| Period end | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale 3 month | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale 6 month | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale 9 month | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.80M 10-Q · filed 2026-08-07 | $21.10M 10-Q · filed 2026-08-07 | $28.40M derived: sum of 3 quarters · filed 2026-08-07 | $44.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $10.30M 10-Q · filed 2026-05-01 | $17.60M derived: sum of 2 quarters · filed 2026-05-01 | $33.90M derived: sum of 3 quarters · filed 2026-05-01 | $42.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.60M derived: sum of 2 quarters · filed 2026-02-26 | $32.30M derived: sum of 3 quarters · filed 2026-08-07 | $32.30M 10-K · filed 2026-02-26 |
| 2025-09-30 | $16.30M 10-Q · filed 2025-10-31 | $25.00M derived: sum of 2 quarters · filed 2026-08-07 | $25.00M 10-Q · filed 2025-10-31 | $25.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $8.70M 10-Q · filed 2026-08-07 | $8.70M 10-Q · filed 2026-08-07 | $8.70M derived: sum of 3 quarters · filed 2026-08-07 | $8.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-05-01 | $0.00 derived: sum of 3 quarters · filed 2026-05-01 | $0.00 derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 10-Q · filed 2025-10-31 | $0.00 derived: sum of 2 quarters · filed 2025-10-31 | $0.00 10-Q · filed 2025-10-31 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |